indazoles has been researched along with Dermatitis, Allergic Contact in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZL; Lai, Y; Li, H; Li, LM; Li, MH; Liu, J; Liu, Y; Luo, XY; Wang, YT; Yang, SX; Yang, T; Zou, Q | 1 |
| Hata, M; Iwakiri, K; Miura, Y; Numano, K; Sasaki, E; Yuge, M | 1 |
1 review(s) available for indazoles and Dermatitis, Allergic Contact
| Article | Year |
|---|---|
Allergic contact dermatitis due to bendazac and alclometasone dipropionate.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Dermatitis, Allergic Contact; Female; Humans; Indazoles; Male; Methylprednisolone; Middle Aged; Patch Tests | 1999 |
1 other study(ies) available for indazoles and Dermatitis, Allergic Contact
| Article | Year |
|---|---|
A novel water-soluble benzothiazole derivative BD926 inhibits human activated T cell proliferation by down-regulating the STAT5 activation.
Topics: Animals; Benzimidazoles; Benzothiazoles; Cell Proliferation; Cells, Cultured; Cyclin D3; Cyclin-Dependent Kinase 6; Cytokines; Dermatitis, Allergic Contact; Dinitrofluorobenzene; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Female; G1 Phase Cell Cycle Checkpoints; Humans; Immunosuppressive Agents; Indazoles; Lymphocyte Activation; Mice, Inbred BALB C; Phosphorylation; Signal Transduction; Solubility; STAT5 Transcription Factor; T-Lymphocytes; Water | 2015 |